| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000001075 |
| Receipt No. | R000001307 |
| Scientific Title | Intraoperative fluorescent imaging techniques using indocyanine green for cholangiography and identification of primary and secondary liver cancers |
| Date of disclosure of the study information | 2008/03/21 |
| Last modified on | 2020/03/24 (Ver. 8) |
| Basic information | ||
| Public title | Intraoperative fluorescent imaging techniques using indocyanine green for cholangiography and identification of primary and secondary liver cancers | |
| Acronym | Intraoperative fluorescent imaging with ICG for cholangiography and identification of liver cancers | |
| Scientific Title | Intraoperative fluorescent imaging techniques using indocyanine green for cholangiography and identification of primary and secondary liver cancers | |
| Scientific Title:Acronym | Intraoperative fluorescent imaging with ICG for cholangiography and identification of liver cancers | |
| Region |
|
|
| Condition | ||
| Condition | Malignant or benign hepatobiliary diseases which require surgeries | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | 1 To evaluate the ability of fluorescent imaging techniques to delineate biliary tracts during surgery
2 To evaluate the ability of fluorescent imaging techniques to detect primary and secondary liver cancers on liver surfaces during surgery or on surgical specimens |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1 Detectability of biliary tracts
2 Detectability of liver cancers |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Fluorescent imaging techniques using intrabiliary or intravenously-injected indocyanine green for intraoperative cholangiography and/or identification of liver cancers | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1 Patients who are to undergo hepatibiliary surgery which will require intraoperative cholangiography
2 Patients who are to undergo liver resection for primary or secondary liver cancers |
|||
| Key exclusion criteria | Patients with a past history of allergic reactions to iodine | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, University of Tokyo | ||||||
| Division name | Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan | ||||||
| TEL | 03-3815-5411 | ||||||
| KOKUDO-2SU@h.u-tokyo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine, University of Tokyo | ||||||
| Division name | Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3815-5411 | ||||||
| Homepage URL | |||||||
| tish-tky@umin.ac.jp | |||||||
| Sponsor | |
| Institute | University of Tokyo Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University of Tokyo Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | SOCIAL INSURANCE CENTRAL GENERAL HOSPITAL |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The University of Tokyo |
| Address | 7-3-1 Hongo Bunkyo-ku Tokyo |
| Tel | 03-3815-5411 |
| liaison@m.u-tokyo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | None |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | 10.1097/MD.0000000000001005, 10.1097/MD.0000000000001005 | ||||||
| Number of participants that the trial has enrolled | 278 | ||||||
| Results | Fluorescence cholangiography delineated the confluence between the cystic duct and common hepatic duct before and after dissection of triangle of Calot in 80 patients and 99 patients, respectively. In hepatectomy, ICG fluorescence imaging enabled identification of 273 of 276 HCCs in the resected specimens. HCCs showed that concerous-type fluorescence was associated with higher cancer cell differentiation as compared with rim-type HCCs (P less than 0.001). |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Patients undergoing laparoscopic cholecystectomy (n=108) or hepatectomy (n=170) |
||||||
| Participant flow | 1) Following preoperative intravenous injection of ICG (2.5mg), fluorescence images of the extrahepatic bile ducts were obtained with near-infrared camera systems. 2) Following preoperative intravenous injection of ICG (0.5 mg/kg), fluorescence imaging of the hepatic surfaces and resected specimens were performed. |
||||||
| Adverse events | None |
||||||
| Outcome measures | Detectabilities of the extrahepatic bile ducts and hepatic tumors during surgery by ICG-fluorescence imaging. |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000001307 |